Location: Virtual | 11 a.m. - 12 p.m. GMT+8
This webinar presents an overview of the contamination control strategy (CCS) process in a medicinal production facility. We introduce the European Compliance Academy (ECA) template as a tool for documenting the CCS process with examples of elements to consider, including cleaning, decontamination, sterilization and sterility maintenance.
The webinar also covers an overview of Annex 1 changes in contamination control and a discussion of challenges manufacturers may face with the holistic CCS approach. We discuss how to leverage modern technology (e.g., software, virtual reality) and statistical analysis to overcome these challenges. Finally, attendees will participate in a survey to share their experience and benchmark status regarding Annex 1 implementation.
Thank you for your interest, but the broadcast date for this webinar has passed. Please refer to our Events page to view upcoming events.
Don’t Miss the Other Webinars in Our “Navigating Annex 1” Series
Cleaning and Sterilization of Product Contact Equipment for Compliance with Annex 1 – Part I
Thursday, 25 May 2023
11 a.m. – 12 p.m. CST (GMT+8)
Cleaning and Sterilization of Product Contact Equipment for Compliance with Annex 1 – Part II
Tuesday, 13 June 2023
6 p.m. - 7 p.m. CST (GMT+8)
Environmental Cleaning, Decontamination, Biodecontamination and Disinfection for Compliance with Annex 1
Tuesday, 25 July 2023
6 p.m. - 7 p.m. CST (GMT+8)
Meet the Presenter
Walid El Azab Senior Manager, Technical Services, has over 13 years of experience as an Industrial Pharmacist. He provides technical support for STERIS Life Sciences Customers for cleaning, disinfectants, sterility assurance, and process validation. Walid holds a master’s degree in pharmaceutical sciences and an additional master’s degree in industrial pharmaceutical sciences.
Areas of expertise for Walid include upstream and downstream pharmaceutical operation and validation in non-sterile and sterile processes. His previous experience includes project management, handling deviations and complaints, releasing raw materials, conducting external audits of suppliers, leading Customer and regulatory audits and developing strategies for process cleaning and system gap analysis.
As a member of the Technical Services team at STERIS Life Sciences, Walid supports Customers with the development of contamination control program, provides guidance on cleaning and disinfection and assists with the creation of technical literature.
Walid is an active member of the Parenteral Drug Association (PDA), the International Society for Pharmaceutical Engineering (ISPE), the European Compliance Academy (ECA) and the Association for Clean and Parenteral Products (A3P). He has published several articles and book chapters on contamination control. Walid has been involved in the creation of several industry guidelines, including CCS and derouging and passivation guidelines. He is also active with the A3P GIC working groups on sterilization, derouging and passivation, GMP Annex 1, and Contamination Control strategy. Walid is also part of the ECA EU GMP Annex 1 task force and leads the ECA task force on contamination control strategy.